Table 1.

Options for prerequisites or readiness criteria for OPV cessation

(a) Prerequisite or readiness criteria prior to 2016 OPV2 cessation and completion status prior to OPV2 cessation
Option	Prior	Done
Global certification of the eradication of indigenous homotypic WPV	Y	Y
Stockpile(s) homotypic OPV (Sabin) vaccine for outbreak response	Y	Y
End transmission of homotypic cVDPV prior to homotypic cessation	Y	N
Increase homotypic population immunity to transmission prior to cessation	Y	N
Develop protocols and needed financial resources for outbreak response	Y	N
Achieve specific minimum immunization dose or coverage targets using IPV	Y	N
Achieve specific minimum immunization dose or coverage targets using OPV	N
Stockpile(s) homotypic nOPV vaccine for outbreak response	N
Institute requirements for surveillance	N
Implement containment for homotypic WPV	N
(b) Risk management strategies that could represent post-OPV cessation prerequisites or readiness criteria
Develop plans for OPV restart that should include specific trigger(s)
Ensure accountable management of outbreak response resources
Ensure sufficient quantities of polio vaccines needed for national RI programs
Implement plans to manage risks of immunodeficiency-associated VDPV
Develop communication strategies to facilitate risk management
Stockpile(s) homotypic novel OPV vaccine for outbreak response